PMID- 26721522 OWN - NLM STAT- MEDLINE DCOM- 20161214 LR - 20161230 IS - 1095-9319 (Electronic) IS - 0026-2862 (Linking) VI - 105 DP - 2016 May TI - Endothelial dysfunction evaluated by peripheral arterial tonometry is related with peak TnI values in patients with ST elevation myocardial infarction treated with primary angioplasty. PG - 34-9 LID - S0026-2862(15)30048-0 [pii] LID - 10.1016/j.mvr.2015.12.010 [doi] AB - PURPOSE: The role of endothelial-dependent function in patients with acute ST elevation myocardial infarction (STEMI) is not clear. Endothelial dysfunction may contribute to the pathophysiological processes occurring after STEMI and influence the extension of myocardial necrosis. Endothelial-dependent dysfunction evaluated by peripheral arterial tonometry (PAT) has already showed to be correlated with microvascular coronary endothelial dysfunction. Our purpose was to evaluate the impact of endothelial dysfunction on peak Troponin I (TnI) values, as a surrogate for the extension of myocardial infarction, in patients with STEMI treated with primary angioplasty (P-PCI). METHODS: 58 patients with STEMI treated with P-PCI (mean age 59.0 +/- 14.0 years, 46 males) were included. Endothelial function was assessed by reactive hyperaemia index (RHI) determined by PAT. Patients were divided in two groups according to the previously reported RHI threshold for high risk (1.67). The extension of myocardial necrosis was evaluated by peak TnI levels. RESULTS: RHI median value was 1.78 (IQR0.74);25 patients had endothelial dysfunction (RHI b 1.67). The two groups had no significant differences in age, gender, main risk factors and pain-to-balloon time. Patients with an RHI b 1.67 had significant larger infarcts: TnI 73.5 ng/mL (IQR 114.42 ng/mL) versus TnI 33.2 ng/mL (IQR 65.2 ng/mL); p = 0.028. On multivariate analysis, the presence of an RHI b 1.67 kept significant impact on TnI peak values (p=0.02). CONCLUSIONS: The presence of endothelial-dependent dysfunction, assessed by PAT, is related with higher peak TnI values in STEMI patients treated with P-PCI. These results strength the possibility that endothelial-dependent dysfunction may be a marker of poor prognosis and eventually a therapeutic target in patients with STEMI. FAU - Baptista, Sergio Bravo AU - Baptista SB AD - Cardiology Department, Hospital Fernando Fonseca, Amadora, Portugal. Electronic address: sergio.b.baptista@gmail.com. FAU - Faustino, Mariana AU - Faustino M AD - Cardiology Department, Hospital Fernando Fonseca, Amadora, Portugal. Electronic address: marianafaustino85@gmail.com. FAU - Simoes, Joana AU - Simoes J AD - Cardiology Department, Hospital Fernando Fonseca, Amadora, Portugal. FAU - Nedio, Maura AU - Nedio M AD - Cardiology Department, Hospital Fernando Fonseca, Amadora, Portugal. FAU - Monteiro, Celia AU - Monteiro C AD - Cardiology Department, Hospital Fernando Fonseca, Amadora, Portugal. FAU - Lourenco, Elsa AU - Lourenco E AD - Cardiology Department, Hospital Fernando Fonseca, Amadora, Portugal. FAU - Leal, Paulo AU - Leal P AD - Cardiology Department, Hospital Fernando Fonseca, Amadora, Portugal. FAU - Farto eAbreu, Pedro AU - Farto eAbreu P AD - Cardiology Department, Hospital Fernando Fonseca, Amadora, Portugal. FAU - Gil, Victor AU - Gil V AD - Cardiology Department, Hospital Fernando Fonseca, Amadora, Portugal. LA - eng PT - Journal Article DEP - 20151222 PL - United States TA - Microvasc Res JT - Microvascular research JID - 0165035 RN - 0 (Biomarkers) RN - 0 (Troponin I) SB - IM MH - Adult MH - Aged MH - Biomarkers/blood MH - Chi-Square Distribution MH - Coronary Circulation MH - Endothelium, Vascular/*physiopathology MH - Female MH - Fingers/*blood supply MH - Humans MH - Hyperemia/physiopathology MH - Linear Models MH - Male MH - Manometry/*methods MH - Microcirculation MH - Middle Aged MH - Multivariate Analysis MH - Myocardial Infarction/blood/diagnosis/physiopathology/*therapy MH - Myocardial Reperfusion Injury/blood/*diagnosis/etiology/physiopathology MH - *Percutaneous Coronary Intervention/adverse effects MH - Predictive Value of Tests MH - Prospective Studies MH - Risk Factors MH - Treatment Outcome MH - Troponin I/*blood MH - Up-Regulation OTO - NOTNLM OT - Acute ST elevation myocardial infarction OT - Endothelial dysfunction OT - Primary angioplasty OT - Reactive hyperaemia index OT - Troponin I EDAT- 2016/01/02 06:00 MHDA- 2016/12/15 06:00 CRDT- 2016/01/02 06:00 PHST- 2015/04/18 00:00 [received] PHST- 2015/11/11 00:00 [revised] PHST- 2015/12/20 00:00 [accepted] PHST- 2016/01/02 06:00 [entrez] PHST- 2016/01/02 06:00 [pubmed] PHST- 2016/12/15 06:00 [medline] AID - S0026-2862(15)30048-0 [pii] AID - 10.1016/j.mvr.2015.12.010 [doi] PST - ppublish SO - Microvasc Res. 2016 May;105:34-9. doi: 10.1016/j.mvr.2015.12.010. Epub 2015 Dec 22.